This trial is withdrawn!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Breast Cancer or Fatigue
and you are
This is an observational trial.
You are contributing to medical knowledge about your condition.
Show me locations

The purpose

RATIONALE: Studying samples of blood from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to fatigue. PURPOSE: This research study is looking at biological markers of fatigue in women with residual invasive breast cancer enrolled on clinical trial NSABP-B-45.

Provided treatments

  • Genetic: gene expression analysis
  • Genetic: microarray analysis
  • Genetic: polymerase chain reaction
  • Genetic: polymorphism analysis
  • Genetic: reverse transcriptase-polymerase chain reaction
  • Other: biologic sample preservation procedure
  • Other: enzyme-linked immunosorbent assay
  • Other: laboratory biomarker analysis
  • Procedure: fatigue assessment and management
Tris trial is registered with FDA with number: NCT00914043. The sponsor of the trial is NSABP Foundation Inc and it is looking for 0 volunteers for the current phase.
Official trial title:
Biobehavioral Mechanisms of Fatigue in Patients Treated on NSABP B-45: A Phase III Clinical Trial Comparing Adjuvant Sunitinib Malate to Placebo in Women With Residual Invasive Breast Cancer Following Neoadjuvant Chemotherapy